Next Article in Journal
Development of Convenient System for Detecting Yeast Cell Stress, Including That of Amyloid Beta
Next Article in Special Issue
Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
Previous Article in Journal
Intrinsic Oncogenic Function of Intracellular Connexin26 Protein in Head and Neck Squamous Cell Carcinoma Cells
Previous Article in Special Issue
The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases
Article

In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators

1
Institute of Sciences of Food Production, C.N.R. Unit of Lecce, via Monteroni, I-73100 Lecce, Italy
2
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK
3
Leicester Institute of Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester LE1 7RH, UK
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 2135; https://doi.org/10.3390/ijms19072135
Received: 6 June 2018 / Revised: 10 July 2018 / Accepted: 19 July 2018 / Published: 23 July 2018
(This article belongs to the Special Issue Glycosylation and Glycoproteins 2017)
Small molecule modulators of the Endoplasmic Reticulum glycoprotein folding quality control (ERQC) machinery have broad-spectrum antiviral activity against a number of enveloped viruses and have the potential to rescue secretion of misfolded but active glycoproteins in rare diseases. In vivo assays of candidate inhibitors in mammals are expensive and cannot be afforded at the preliminary stages of drug development programs. The strong conservation of the ERQC machinery across eukaryotes makes transgenic plants an attractive system for low-cost, easy and fast proof-of-concept screening of candidate ERQC inhibitors. The Arabidopsis thaliana immune response is mediated by glycoproteins, the folding of which is controlled by ERQC. We have used the plant response to bacterial peptides as a means of assaying an ERQC inhibitor in vivo. We show that the treatment of the plant with the iminosugar NB-DNJ, which is a known ER α-glucosidase inhibitor in mammals, influences the immune response of the plant to the bacterial peptide elf18 but not to the flagellin-derived flg22 peptide. In the NB-DNJ-treated plant, the responses to elf18 and flg22 treatments closely follow the ones observed for the ER α-glucosidase II impaired plant, At psl5-1. We propose Arabidopsis thaliana as a promising platform for the development of low-cost proof-of-concept in vivo ERQC modulation. View Full-Text
Keywords: endoplasmic reticulum; glycoprotein folding quality control; Arabidopsis thaliana; drug screening; iminosugar; NB-DNJ; plant immune response endoplasmic reticulum; glycoprotein folding quality control; Arabidopsis thaliana; drug screening; iminosugar; NB-DNJ; plant immune response
Show Figures

Figure 1

MDPI and ACS Style

Marti, L.; Lia, A.; Reca, I.-B.; Roversi, P.; Santino, A.; Zitzmann, N. In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators. Int. J. Mol. Sci. 2018, 19, 2135. https://doi.org/10.3390/ijms19072135

AMA Style

Marti L, Lia A, Reca I-B, Roversi P, Santino A, Zitzmann N. In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators. International Journal of Molecular Sciences. 2018; 19(7):2135. https://doi.org/10.3390/ijms19072135

Chicago/Turabian Style

Marti, Lucia, Andrea Lia, Ida-Barbara Reca, Pietro Roversi, Angelo Santino, and Nicole Zitzmann. 2018. "In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators" International Journal of Molecular Sciences 19, no. 7: 2135. https://doi.org/10.3390/ijms19072135

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop